Avantor Investor Conference Presentation Deck

Exposed to attractive end markets TOTAL ADDRESSABLE MARKET >$80B BIOPHARMA + HSD growth rate >70% LIFE SCIENCE EXPOSURE Navantor™ 55% ~10% $7.5B -10% 2022 REVENUE ~25% HEALTHCARE + MSD growth rate All growth rates represent expected long-term growth rates. HSD = 7-9%; MSD = 4-6%; LSD = 1-3% 2022 data based on full year results. EDUCATION & GOVERNMENT + LSD growth rate ADVANCED TECH & APPLIED MATERIALS + MSD growth rate 4

View entire presentation